| Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping (NCT06561022) | Fudan University | 2024-08-21 |
| Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV (NCT06560840) | Fudan University | 2024-08-20 |
| HTA of NIVATS Based on RWE (NCT06574295) | Fudan University | 2024-08-20 |
| Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment (NCT07711171) | Fudan University | 2024-08-19 |
| A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors (NCT06553846) | Fudan University | 2024-08-19 |
| A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease. (NCT06561555) | Fudan University | 2024-08-15 |
| MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer (NCT06840665) | Fudan University | 2024-08-13 |
| Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (NCT06519526) | Fudan University | 2024-08-12 |
| A Real World Study of Sacituzumab Govitecan (NCT06966141) | Fudan University | 2024-08-12 |
| Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis (NCT07079462) | Fudan University | 2024-08-07 |
| ADC-induced Neurotoxicity Treated With Duloxetine (NCT06551051) | Fudan University | 2024-08-06 |
| Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease (NCT06525415) | Fudan University | 2024-08-01 |
| Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer (NCT06331169) | Fudan University | 2024-07-31 |
| A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab (NCT06513221) | Fudan University | 2024-07-25 |
| HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma (NCT06475287) | Fudan University | 2024-07-20 |
| Effectiveness of Gut Microbiota-targeted Diatery Intervention Among People Living With HIV (NCT06498401) | Fudan University | 2024-07-20 |
| An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT06517004) | Fudan University | 2024-07-18 |
| RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer (NCT06530316) | Fudan University | 2024-07-18 |
| Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer (NCT06503380) | Fudan University | 2024-07-15 |
| Adjuvant Radiotherapy in High Risk Locally Advanced DTC (NCT06558981) | Fudan University | 2024-07-11 |
| AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy (NCT06494995) | Fudan University | 2024-07-03 |
| RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer (NCT06524167) | Fudan University | 2024-07-02 |
| Segmentectomy for Solid-dominant Lung Cancer (NCT06634966) | Fudan University | 2024-07-01 |
| Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis (NCT06501378) | Fudan University | 2024-07-01 |
| Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma (NCT06441019) | Fudan University | 2024-07-01 |
| Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma (NCT06728657) | Fudan University | 2024-07-01 |
| Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC (NCT06448910) | Fudan University | 2024-07-01 |
| Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial (NCT06468969) | Fudan University | 2024-07-01 |
| Multi-omics Model for Pancreatic Cancer Screening Using cfDNA (NCT06456281) | Fudan University | 2024-06-28 |
| A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS (NCT06545994) | Fudan University | 2024-06-28 |
| Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC (NCT06494943) | Fudan University | 2024-06-26 |
| First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients (NCT06313970) | Fudan University | 2024-06-20 |
| Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China (NCT06484140) | Fudan University | 2024-06-17 |
| Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma (NCT06427239) | Fudan University | 2024-06-17 |
| Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer (NCT06475326) | Fudan University | 2024-06-05 |
| PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients (NCT06359275) | Fudan University | 2024-06-01 |
| Combination of Toripalimab and JS004 Therapy for ccRCC (NCT06690697) | Fudan University | 2024-06-01 |
| A Cohort Study in Newly Diagnosed MZL (NCT06449885) | Fudan University | 2024-05-30 |
| A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma (NCT06341556) | Fudan University | 2024-05-24 |
| Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis (NCT07531069) | Fudan University | 2024-05-21 |
| Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma (NCT06313554) | Fudan University | 2024-05-20 |
| Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer (NCT06355037) | Fudan University | 2024-05-20 |
| Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer (NCT06250972) | Fudan University | 2024-05-15 |
| Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer (NCT06355024) | Fudan University | 2024-05-11 |
| The Impact of Colorectal Cancer Screening on Surgical Outcomes (NCT06416501) | Fudan University | 2024-05-11 |
| Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE) (NCT06455124) | Fudan University | 2024-05-08 |
| QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer (NCT06404736) | Fudan University | 2024-05-07 |
| QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer (NCT06404463) | Fudan University | 2024-05-06 |
| Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin (NCT06406426) | Fudan University | 2024-05-01 |
| Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study (NCT06390982) | Fudan University | 2024-05-01 |
| Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients (NCT06561620) | Fudan University | 2024-05-01 |
| Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm (NCT06634979) | Fudan University | 2024-05-01 |
| Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer (NCT06423937) | Fudan University | 2024-05-01 |
| Newly Emerging Immunotherapy for Pancreatic Cancer Treatment (NCT06370754) | Fudan University | 2024-04-30 |
| Impact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment (NCT06405048) | Fudan University | 2024-04-28 |
| A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM (NCT06431997) | Fudan University | 2024-04-27 |
| The Antagonistic Effect of Composite Polyphenols on Health Damage Caused by Environmental Pollutants (NCT06437119) | Fudan University | 2024-04-23 |
| Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC (NCT06258642) | Fudan University | 2024-04-17 |
| A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors (NCT06394622) | Fudan University | 2024-04-11 |
| Lymph Node Pathologic Grading Strategy (NCT06745830) | Fudan University | 2024-04-10 |
| Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy (NCT06313541) | Fudan University | 2024-04-10 |
| Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) (NCT06402708) | Fudan University | 2024-04-09 |
| Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib (NCT06341621) | Fudan University | 2024-04-02 |
| Primary Tumor Resection for M1a Stage Lung Cancer (NCT06547710) | Fudan University | 2024-04-01 |
| Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) (NCT05976152) | Fudan University | 2024-04-01 |
| Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery (NCT06263205) | Fudan University | 2024-04-01 |
| Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022) (NCT06323148) | Fudan University | 2024-04-01 |
| Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients (NCT06301386) | Fudan University | 2024-04-01 |
| Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer (NCT06525428) | Fudan University | 2024-04-01 |
| Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase (NCT07555678) | Fudan University | 2024-04-01 |
| Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer (NCT06462053) | Fudan University | 2024-04-01 |
| CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer (NCT06281405) | Fudan University | 2024-03-28 |
| The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota (NCT07400354) | Fudan University | 2024-03-14 |
| clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases (NCT06392217) | Fudan University | 2024-03-12 |
| Metronomic Capecitabine in Stage III Gastric Cancer (NCT06313567) | Fudan University | 2024-03-10 |
| Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma (NCT06314334) | Fudan University | 2024-03-04 |
| Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer (NCT06196788) | Fudan University | 2024-03-01 |
| Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer (NCT06841159) | Fudan University | 2024-03-01 |
| Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer (NCT06356519) | Fudan University | 2024-03-01 |
| Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected Patients (NCT06279819) | Fudan University | 2024-03-01 |
| Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma (NCT06228963) | Fudan University | 2024-03-01 |
| Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study (NCT07236203) | Fudan University | 2024-02-29 |
| Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China (NCT06355440) | Fudan University | 2024-02-18 |
| HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer (NCT06217042) | Fudan University | 2024-02-05 |
| Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer (NCT06447623) | Fudan University | 2024-02-01 |
| SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases (NCT06210438) | Fudan University | 2024-02-01 |
| Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID) (NCT06251492) | Fudan University | 2024-01-30 |
| Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer (NCT06911528) | Fudan University | 2024-01-30 |
| Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China (NCT06227689) | Fudan University | 2024-01-18 |
| Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma (NCT06211790) | Fudan University | 2024-01-16 |
| Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis (NCT06230055) | Fudan University | 2024-01-05 |
| DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases (NCT06177288) | Fudan University | 2024-01-01 |
| Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino (NCT06156267) | Fudan University | 2024-01-01 |
| Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy (NCT07561060) | Fudan University | 2024-01-01 |
| Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy (NCT06167421) | Fudan University | 2024-01-01 |
| Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model (NCT06202404) | Fudan University | 2024-01-01 |
| A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal Endometriosis (NCT06254716) | Fudan University | 2024-01-01 |
| Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer (NCT06218810) | Fudan University | 2024-01-01 |
| Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA (NCT06440902) | Fudan University | 2023-12-28 |
| TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma (NCT06401447) | Fudan University | 2023-12-21 |